212 related articles for article (PubMed ID: 1897382)
21. [Circadian changes in mitotic activity and DNA synthesis in hyperdiploid and hypotetraploid strains of Ehrlich's ascites tumor].
Romanov IuA; Stepanenko VA
Biull Eksp Biol Med; 1980 Feb; 89(2):187-9. PubMed ID: 7370420
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory activity of 6MFA, a compound obtained from fungus Aspergillus ochraceus.
Naik SR; Deshmukh VK; Raman PH
Jpn J Med Sci Biol; 1986 Jun; 39(3):139-49. PubMed ID: 3784110
[TBL] [Abstract][Full Text] [Related]
23. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.
Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN
Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114
[TBL] [Abstract][Full Text] [Related]
24. [Vitamin B6 metabolism in mice with Ehrlich ascites tumor].
Trebukhina RV; Mikhal'tsevich GN
Vopr Pitan; 1982; (1):40-4. PubMed ID: 7072178
[TBL] [Abstract][Full Text] [Related]
25. The antitumor effect of intraperitoneal treatment with rhTNF-alpha muteins on Ehrlich ascites tumor growth.
Terlikowski S; Nowak HF
Cancer Biother Radiopharm; 2000 Feb; 15(1):39-46. PubMed ID: 10740651
[TBL] [Abstract][Full Text] [Related]
26. [The influence of high-frequency hyperthermia on Ehrlich-ascites carcinoma in the mouse].
Dietzel F; Seibert G; Klobe G
Strahlentherapie; 1975 Jan; 149(1):105-17. PubMed ID: 1124551
[TBL] [Abstract][Full Text] [Related]
27. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
[TBL] [Abstract][Full Text] [Related]
28. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
[TBL] [Abstract][Full Text] [Related]
29. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
30. Antitumour and antioxidant activity of Scutia myrtina against Ehrlich ascites carcinoma in Swiss albino mice.
Kumar RS; Kumar KA; Murthy NV
Nat Prod Res; 2012; 26(16):1504-9. PubMed ID: 22007751
[TBL] [Abstract][Full Text] [Related]
31. [Effects of the contamination by polychlorobiphenyls (PCBs) on the growth of the Ehrlich tumor in mice (author's transl)].
Keck G
Toxicol Eur Res; 1981 Sep; 3(5):229-36. PubMed ID: 6803399
[TBL] [Abstract][Full Text] [Related]
32. Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin.
Pal S; Bhattacharyya S; Choudhuri T; Datta GK; Das T; Sa G
Cancer Detect Prev; 2005; 29(5):470-8. PubMed ID: 16188398
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of 6-MFA, a fungal interferon inducer against Japanese encephalitis virus in bonnet macaques.
Ghosh SN; Goverdhan MK; Sathe PS; Chelliah SC; Naik SV; Godbole PV; Banerjee K
Indian J Med Res; 1990 Nov; 91():408-13. PubMed ID: 1965430
[TBL] [Abstract][Full Text] [Related]
34. Effect of uremia on tumor growth in mice.
Roll D; Schwartz N; Ben-Bassat J; Czaczkes JW
Isr J Med Sci; 1978 Sep; 14(9):975-8. PubMed ID: 721426
[TBL] [Abstract][Full Text] [Related]
35. [Decrease in the growth rate of Ehrlich's tumor and Pliss' lymphosarcoma with partial hepatectomy].
Udintsev SN; Shakhov VP
Vopr Onkol; 1989; 35(9):1072-5. PubMed ID: 2573197
[TBL] [Abstract][Full Text] [Related]
36. Tumor inhibition and hematological improvements by dopamine analog 3,4-dihydroxybenzylamine in mice bearing transplantable carcinoma.
Lahiri T; Banerjee S; Dasgupta PS; Ray MR
Neoplasma; 1990; 37(4):387-93. PubMed ID: 2234200
[TBL] [Abstract][Full Text] [Related]
37. Growth retardation and prevention of Ehrlich solid tumor by Clostridium perfringens type A spores and culture supernatant.
Lapointe JR; Portelance V
Cancer Res; 1978 Aug; 38(8):2295-300. PubMed ID: 208766
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
Yamamoto N; Naraparaju VR
Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
[TBL] [Abstract][Full Text] [Related]
39. [Combined effect of an Ehrlich ascites tumor growth-inhibiting extract and adrenaline on cell division by that tumor in vitro].
Romanov IuA; Biks KA; Stepanova LI; Matsak NIa
Biull Eksp Biol Med; 1981 Feb; 91(2):202-4. PubMed ID: 7225558
[TBL] [Abstract][Full Text] [Related]
40. Glutathione reduces the toxicity associated with antitumor therapy of ascites fluid adsorbed over Staphylococcus aureus Cowan I in tumor bearing mice.
Verma AS; Dwivedi PD; Mishra A; Ray PK
Toxicol Lett; 1999 Jun; 106(2-3):119-27. PubMed ID: 10403655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
